Reference health
Recent developments in cancer research: Expectations for a new remedy
1 of 66 checkable references need attention · checked 2026-07-23
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
References needing attention
marked retracted — notice via Crossref, record curated by Retraction Watch10.1016/j.ymthe.2018.07.023
RETRACTED: Exosome-Derived miR-130a Activates Angiogenesis in Gastric Cancer by Targeting C-MYB in Vascular Endothelial Cells
The 65 checked references that resolve
resolves10.3402/jev.v2i0.20424
Comparative marker analysis of extracellular vesicles in different human cancer types
resolves10.1016/j.bulcan.2018.05.003
Exosomes of glioma cells deliver miR-148a to promote proliferation and metastasis of glioblastoma via targeting CADM1
resolves10.1155/2020/7461727
Exosomes Derived from Brain Metastatic Breast Cancer Cells Destroy the Blood‐Brain Barrier by Carrying lncRNA GS1‐600G8.5
resolves10.1186/s12943-019-0991-5
Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance
resolves10.1126/scisignal.2005231
Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells
resolves10.1002/cbic.201800470
Exosomes: Isolation, Analysis, and Applications in Cancer Detection and Therapy
resolves10.1038/ncomms4591
Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen
resolves10.1139/cjm-2016-0603
The oral cavity microbiota: between health, oral disease, and cancers of the aerodigestive tract
resolves10.1038/nrmicro.2017.14
The microbiota of the respiratory tract: gatekeeper to respiratory health
resolves10.7717/peerj.1514
Impact of demographics on human gut microbial diversity in a US Midwest population
resolves10.1186/s12866-016-0708-5
Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study
resolves10.1136/gutjnl-2016-312135
Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease
resolves10.1038/nature12198
Gut metagenome in European women with normal, impaired and diabetic glucose control
resolves10.1038/s41591-019-0458-7
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
resolves10.1200/JCO.2013.53.0105
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
resolves10.1038/s41385-019-0227-4
IgA and the intestinal microbiota: the importance of being specific
resolves10.1038/nmicrobiol.2016.103
High-affinity monoclonal IgA regulates gut microbiota and prevents colitis in mice
resolves10.1038/s41467-019-11893-4
Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56
resolves10.1056/NEJMoa1910836
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
resolves10.1016/S1470-2045(16)30496-X
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial
resolves10.1016/S0140-6736(17)31827-5
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
resolves10.1016/S1470-2045(19)30626-6
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial
resolves10.1038/ni.1674
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
resolves10.1038/nm.4431
The activated conformation of integrin β7 is a novel multiple myeloma–specific target for CAR T cell therapy
resolves10.1200/JCO.2016.71.3024
Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels
resolves10.1038/s41392-020-00256-x
The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma
resolves10.1200/JCO.2017.76.9901
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
resolves10.1126/science.1247125
Organogenesis in a dish: Modeling development and disease using organoid technologies
resolves10.1016/j.cell.2014.08.016
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
resolves10.1016/j.cell.2015.03.053
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
resolves10.1038/nm.3973
Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell– and patient-derived tumor organoids
resolves10.1016/j.jcmgh.2018.09.003
Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells
resolves10.1158/2159-8290.CD-16-1154
Personalized
<i>In Vitro</i>
and
<i>In Vivo</i>
Cancer Models to Guide Precision Medicine
resolves10.1038/nature07935
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
resolves10.1053/j.gastro.2011.07.050
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
resolves10.1016/j.jcmgh.2017.12.013
The Esophageal Organoid System Reveals Functional Interplay Between Notch and Cytokines in Reactive Epithelial Changes
resolves10.1038/nm.3802
Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids
resolves10.1016/j.stem.2016.04.003
A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1002/ags3.12440"><img src="https://citestamp.com/citestamped/10.1002/ags3.12440/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1002/ags3.12440)